BACKGROUND AND AIMS: Given the high risk of subsequent fracture among elderly persons with fracture, it is important to initiate secondary treatment for osteoporosis. Acute rehabilitation centers may offer a unique opportunity to introduce treatment. Therefore, we evaluated willingness-to-participate and compliance with evidence-based interventions for the secondary prevention of osteoporotic fracture in a non-randomized study conducted in the acute rehabilitation setting. We also described differences in baseline characteristics between study participants and non-participants. METHODS: All consecutive, community dwelling admissions to an acute rehabilitation unit (Boston, MA) with the diagnosis of fracture were screened for enrollment. Eligible subjects were offered a free, 6-month supply of alendronate/cholecalciferol (70 mg/2800 IU weekly), calcium and vitamin D supplements, and fall prevention strategies. Six-month compliance (> or =75% consumption of medication or supplement) with the interventions was determined at a home visit. RESULTS: Among 62 eligible subjects, 25 agreed to participate. Non-participants were older than participants (86 vs 80 yrs, p<0.01). There was no significant difference between other characteristics of participants and non-participants including sex, weight, type of fracture, cognitive status, and functional status. The most common reason for non-participation was reluctance to take another medication. Among participants, only 52% were compliant with alendronate and 58% were compliant with calcium and vitamin D supplementation at 6 months. CONCLUSIONS: Willingness- to-participate and compliance with secondary prevention strategies for osteoporosis was low in the acute rehabilitation setting, even when medications were provided free of cost. Educating individuals with fracture and their families on the consequences and treatment of osteoporosis may help to decrease the risk of sustaining a second fracture by accepting secondary preventive measures.
BACKGROUND AND AIMS: Given the high risk of subsequent fracture among elderly persons with fracture, it is important to initiate secondary treatment for osteoporosis. Acute rehabilitation centers may offer a unique opportunity to introduce treatment. Therefore, we evaluated willingness-to-participate and compliance with evidence-based interventions for the secondary prevention of osteoporotic fracture in a non-randomized study conducted in the acute rehabilitation setting. We also described differences in baseline characteristics between study participants and non-participants. METHODS: All consecutive, community dwelling admissions to an acute rehabilitation unit (Boston, MA) with the diagnosis of fracture were screened for enrollment. Eligible subjects were offered a free, 6-month supply of alendronate/cholecalciferol (70 mg/2800 IU weekly), calcium and vitamin D supplements, and fall prevention strategies. Six-month compliance (> or =75% consumption of medication or supplement) with the interventions was determined at a home visit. RESULTS: Among 62 eligible subjects, 25 agreed to participate. Non-participants were older than participants (86 vs 80 yrs, p<0.01). There was no significant difference between other characteristics of participants and non-participants including sex, weight, type of fracture, cognitive status, and functional status. The most common reason for non-participation was reluctance to take another medication. Among participants, only 52% were compliant with alendronate and 58% were compliant with calcium and vitamin D supplementation at 6 months. CONCLUSIONS: Willingness- to-participate and compliance with secondary prevention strategies for osteoporosis was low in the acute rehabilitation setting, even when medications were provided free of cost. Educating individuals with fracture and their families on the consequences and treatment of osteoporosis may help to decrease the risk of sustaining a second fracture by accepting secondary preventive measures.
Authors: Michael J Gardner; Robert H Brophy; Demetris Demetrakopoulos; Jason Koob; Richard Hong; Adam Rana; Julie T Lin; Joseph M Lane Journal: J Bone Joint Surg Am Date: 2005-01 Impact factor: 5.284
Authors: Jeffrey R Curtis; Juan Xi; Andrew O Westfall; Hong Cheng; Kenneth Lyles; Kenneth G Saag; Elizabeth Delzell Journal: Med Care Date: 2009-03 Impact factor: 2.983
Authors: Lora Giangregorio; Alexandra Papaioannou; Lehana Thabane; Justin DeBeer; Ann Cranney; Lisa Dolovich; Anthony Adili; Jonathan D Adachi Journal: BMC Musculoskelet Disord Date: 2008-03-21 Impact factor: 2.362
Authors: A Naranjo; S Ojeda-Bruno; A Bilbao-Cantarero; J C Quevedo-Abeledo; B V Diaz-González; C Rodríguez-Lozano Journal: Osteoporos Int Date: 2015-06-06 Impact factor: 4.507
Authors: C Wölfl; C Takur; A A Moghaddam; G Zimmermann; M Hitzler; H Schmidt-Gayk; B Höner; P A Grützner; L Kolios Journal: Unfallchirurg Date: 2013-02 Impact factor: 1.000
Authors: Francesco Conti; Prisco Piscitelli; Giovanni Italiano; Alessandro Parma; Maria Cristina Caffetti; Lorenzo Giolli; Gian Luca Di Tanna; Andrea Guazzini; Maria Luisa Brandi Journal: Clin Cases Miner Bone Metab Date: 2012-12-20
Authors: A Emamifar; Rannveig Gildberg-Mortensen; S Andreas Just; N Lomborg; R Asmussen Andreasen; I M Jensen Hansen Journal: Int J Rheumatol Date: 2015-09-29